Literature DB >> 25355237

Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.

Frederick A Kweh1, Jennifer L Miller, Carlos R Sulsona, Clive Wasserfall, Mark Atkinson, Jonathan J Shuster, Anthony P Goldstone, Daniel J Driscoll.   

Abstract

Circulating total ghrelin levels are elevated in older children and adults with Prader-Willi syndrome (PWS). However, the presence or absence of hyperghrelinemia in young children with PWS remains controversial. We hypothesized that a more robust way to analyze appetite-regulating hormones in PWS would be by nutritional phases rather than age alone. Our objectives were to compare total serum ghrelin levels in children with PWS by nutritional phase as well as to compare total ghrelin levels in PWS (5 weeks to 21 years of age) to normal weight controls and individuals with early-onset morbid obesity (EMO) without PWS. Fasting serum total ghrelin levels were measured in 60 subjects with PWS, 39 subjects with EMO of unknown etiology, and in 95 normal non-obese sibling controls of PWS or EMO subjects (SibC) in this 12 year longitudinal study. Within PWS, total ghrelin levels were significantly (P < 0.001) higher in earlier nutritional phases: phase 1a (7,906  ±  5,887); 1b (5,057 ± 2,624); 2a (2,905 ± 1,521); 2b (2,615 ± 1,370) and 3 (2,423 ± 1,350). Young infants with PWS also had significantly (P = 0.009) higher total ghrelin levels than did the sibling controls. Nutritional phase is an important independent prognostic factor of total ghrelin levels in individuals with PWS. Circulating ghrelin levels are elevated in young children with PWS long before the onset of hyperphagia, especially during the early phase of poor appetite and feeding. Therefore, it seems unlikely that high ghrelin levels are directly responsible for the switch to the hyperphagic nutritional phases in PWS.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Prader-Willi; ghrelin; hyperghrelinemia; hyperphagia; nutritional phase; obesity

Mesh:

Substances:

Year:  2014        PMID: 25355237      PMCID: PMC4391201          DOI: 10.1002/ajmg.a.36810

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  46 in total

1.  Fasting and post-glucose ghrelin levels in SGA infants: relationships with size and weight gain at one year of age.

Authors:  Germán Iñiguez; Ken Ong; Veronica Peña; Alejandra Avila; David Dunger; Veronica Mericq
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  The relationship of active ghrelin levels and intrauterine growth in preterm infants.

Authors:  Hamilcikan Sahin; Tugba Erener; Ethem Erginoz; Mehmet Vural; Barbaros Ilikkan; Sultan Kavuncuoglu; Hayrettin Yildiz; Yildiz Perk
Journal:  Eur J Endocrinol       Date:  2011-12-05       Impact factor: 6.664

Review 3.  Developmental effects of ghrelin.

Authors:  Sophie M Steculorum; Sebastien G Bouret
Journal:  Peptides       Date:  2011-06-28       Impact factor: 3.750

Review 4.  Stimulation of appetite by ghrelin is regulated by leptin restraint: peripheral and central sites of action.

Authors:  Satya P Kalra; Naohiko Ueno; Pushpa S Kalra
Journal:  J Nutr       Date:  2005-05       Impact factor: 4.798

5.  Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.

Authors:  Anthony P Goldstone; Michael Patterson; Nila Kalingag; Mohammad A Ghatei; Audrey E Brynes; Stephen R Bloom; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

6.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

7.  Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis.

Authors:  Maithé Tauber; Françoise Conte Auriol; Pierre Moulin; Catherine Molinas; Véronique Delagnes; Jean Pierre Salles
Journal:  Horm Res       Date:  2004-06-08

Review 8.  Gut hormones and appetite control.

Authors:  A M Wren; S R Bloom
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

9.  Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.

Authors:  Andrea M Haqq; I Sadaf Farooqi; Stephen O'Rahilly; Diane D Stadler; Ron G Rosenfeld; Katherine L Pratt; Stephen H LaFranchi; Jonathan Q Purnell
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

10.  The transition between the phenotypes of Prader-Willi syndrome during infancy and early childhood.

Authors:  Jill V Butler; Joyce E Whittington; Anthony J Holland; Catherine J McAllister; Anthony P Goldstone
Journal:  Dev Med Child Neurol       Date:  2009-12-23       Impact factor: 5.449

View more
  26 in total

1.  Prader-Willi Syndrome due to an Unbalanced de novo Translocation t(15;19)(q12;p13.3).

Authors:  Vy Dang; Abhilasha Surampalli; Ann M Manzardo; Stephanie Youn; Merlin G Butler; June-Anne Gold; Virginia E Kimonis
Journal:  Cytogenet Genome Res       Date:  2016-11-29       Impact factor: 1.636

2.  Synthetic Triterpenoid Inhibition of Human Ghrelin O-Acyltransferase: The Involvement of a Functionally Required Cysteine Provides Mechanistic Insight into Ghrelin Acylation.

Authors:  Kayleigh R McGovern-Gooch; Nivedita S Mahajani; Ariana Garagozzo; Anthony J Schramm; Lauren G Hannah; Michelle A Sieburg; John D Chisholm; James L Hougland
Journal:  Biochemistry       Date:  2017-02-07       Impact factor: 3.162

3.  Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone.

Authors:  Krystal A Irizarry; James Bain; Merlin G Butler; Olga Ilkayeva; Michael Muehlbauer; Andrea M Haqq; Michael Freemark
Journal:  Clin Endocrinol (Oxf)       Date:  2015-04-01       Impact factor: 3.478

Review 4.  Epigenetic therapy of Prader-Willi syndrome.

Authors:  Yuna Kim; Sung Eun Wang; Yong-Hui Jiang
Journal:  Transl Res       Date:  2019-03-05       Impact factor: 7.012

5.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

6.  Loss of Magel2 impairs the development of hypothalamic Anorexigenic circuits.

Authors:  Julien Maillard; Soyoung Park; Sophie Croizier; Charlotte Vanacker; Joshua H Cook; Vincent Prevot; Maithe Tauber; Sebastien G Bouret
Journal:  Hum Mol Genet       Date:  2016-06-10       Impact factor: 6.150

Review 7.  The cellular and molecular bases of leptin and ghrelin resistance in obesity.

Authors:  Huxing Cui; Miguel López; Kamal Rahmouni
Journal:  Nat Rev Endocrinol       Date:  2017-02-24       Impact factor: 43.330

Review 8.  An overview of ghrelin O-acyltransferase inhibitors: a literature and patent review for 2010-2019.

Authors:  Jacob E Moose; Katelyn A Leets; Nilamber A Mate; John D Chisholm; James L Hougland
Journal:  Expert Opin Ther Pat       Date:  2020-06-21       Impact factor: 6.674

9.  Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model.

Authors:  Juan A Rodriguez; Emily C Bruggeman; Bharath K Mani; Sherri Osborne-Lawrence; Caleb C Lord; Henry F Roseman; Hannah L Viroslav; Prasanna Vijayaraghavan; Nathan P Metzger; Deepali Gupta; Kripa Shankar; Claudio Pietra; Chen Liu; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

10.  Impaired prohormone processing: a grand unified theory for features of Prader-Willi syndrome?

Authors:  Joseph Polex-Wolf; Giles S H Yeo; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.